Cabot Corporation (NYSE:CBT) Shares Purchased by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC increased its holdings in shares of Cabot Corporation (NYSE:CBTFree Report) by 26.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,317 shares of the specialty chemicals company’s stock after acquiring an additional 489 shares during the period. Nisa Investment Advisors LLC’s holdings in Cabot were worth $193,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the company. Beverly Hills Private Wealth LLC grew its stake in Cabot by 3.6% during the 1st quarter. Beverly Hills Private Wealth LLC now owns 3,918 shares of the specialty chemicals company’s stock valued at $326,000 after purchasing an additional 135 shares in the last quarter. Penserra Capital Management LLC bought a new stake in Cabot during the 1st quarter valued at $331,000. Lightrock Netherlands B.V. raised its stake in Cabot by 74.8% during the 1st quarter. Lightrock Netherlands B.V. now owns 118,644 shares of the specialty chemicals company’s stock valued at $9,881,000 after acquiring an additional 50,778 shares in the last quarter. Leeward Investments LLC MA increased its position in shares of Cabot by 13.3% during the 1st quarter. Leeward Investments LLC MA now owns 181,619 shares of the specialty chemicals company’s stock valued at $15,100,000 after purchasing an additional 21,373 shares during the period. Finally, Monument Capital Management increased its position in shares of Cabot by 10.9% during the 1st quarter. Monument Capital Management now owns 31,636 shares of the specialty chemicals company’s stock valued at $2,630,000 after purchasing an additional 3,120 shares during the period. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Price Performance

CBT stock opened at $76.30 on Friday. Cabot Corporation has a 12-month low of $71.64 and a 12-month high of $117.46. The company has a quick ratio of 1.30, a current ratio of 1.96 and a debt-to-equity ratio of 0.69. The firm has a market cap of $4.10 billion, a price-to-earnings ratio of 9.87, a PEG ratio of 0.68 and a beta of 0.85. The company’s fifty day simple moving average is $75.79 and its 200 day simple moving average is $81.07.

Cabot (NYSE:CBTGet Free Report) last posted its earnings results on Monday, May 5th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.86 by $0.04. Cabot had a net margin of 11.08% and a return on equity of 26.76%. The business had revenue of $936.00 million for the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the prior year, the company posted $1.78 EPS. The business’s revenue for the quarter was down 8.1% compared to the same quarter last year. On average, analysts expect that Cabot Corporation will post 7.57 earnings per share for the current year.

Cabot Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 11th. Shareholders of record on Friday, August 29th will be issued a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.36%. Cabot’s dividend payout ratio (DPR) is presently 23.29%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on CBT. Wall Street Zen downgraded Cabot from a “buy” rating to a “hold” rating in a report on Wednesday, May 7th. UBS Group dropped their price objective on Cabot from $93.00 to $83.00 and set a “neutral” rating on the stock in a research note on Monday, April 7th.

Check Out Our Latest Research Report on Cabot

Cabot Profile

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Read More

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.